126 related articles for article (PubMed ID: 3417566)
1. In vitro and in vivo evaluation of C-20- and C-23-modified derivatives of tylosin against veterinary pathogens.
Kirst HA; Ose EE; Toth JE; Willard KE; Debono M; Felty-Duckworth AM; Pekarek RS
J Antibiot (Tokyo); 1988 Jul; 41(7):938-48. PubMed ID: 3417566
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimicrobial evaluation of 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin (tilmicosin, EL-870) and related cyclic amino derivatives.
Debono M; Willard KE; Kirst HA; Wind JA; Crouse GD; Tao EV; Vicenzi JT; Counter FT; Ott JL; Ose EE
J Antibiot (Tokyo); 1989 Aug; 42(8):1253-67. PubMed ID: 2668243
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity studies of 20-deoxo-20-amino derivatives of tylosin-related macrolides.
Kirst HA; Willard KE; Debono M; Toth JE; Truedell BA; Leeds JP; Ott JL; Felty-Duckworth AM; Counter FT; Ose EE
J Antibiot (Tokyo); 1989 Nov; 42(11):1673-83. PubMed ID: 2684947
[TBL] [Abstract][Full Text] [Related]
4. In vitro antibacterial properties of EL-870, a new semi-synthetic macrolide antibiotic.
Ose EE
J Antibiot (Tokyo); 1987 Feb; 40(2):190-4. PubMed ID: 3570967
[TBL] [Abstract][Full Text] [Related]
5. Repromicin derivatives with potent antibacterial activity against Pasteurella multocida.
McFarland JW; Hecker SJ; Jaynes BH; Jefson MR; Lundy KM; Vu CB; Glazer EA; Froshauer SA; Hayashi SF; Kamicker BJ; Reese CP; Olson JA
J Med Chem; 1997 Mar; 40(6):1041-5. PubMed ID: 9083494
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimicrobial evaluation of acyl derivatives of 16-membered macrolide antibiotics related to tylosin.
Kirst HA; Debono M; Toth JE; Truedell BA; Willard KE; Ott JL; Counter FT; Felty-Duckworth AM; Pekarek RS
J Antibiot (Tokyo); 1986 Aug; 39(8):1108-22. PubMed ID: 3759662
[TBL] [Abstract][Full Text] [Related]
7. Preliminary clinical pharmacological investigations of tylosin and tiamulin in chickens.
Ziv G
Tijdschr Diergeneeskd; 1980 Oct; 105(20):206-10. PubMed ID: 7444918
[TBL] [Abstract][Full Text] [Related]
8. Biological properties of new acyl derivatives of tylosin.
Okamoto R; Tsuchiya M; Nomura H; Iguchi H; Kiyoshima K; Hori S; Inui T; Sawa T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Nov; 33(11):1309-15. PubMed ID: 7251472
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of tylosin-related macrolides modified at the aldehyde function: a new series of orally effective antibiotics.
Kirst HA; Toth JE; Debono M; Willard KE; Truedell BA; Ott JL; Counter FT; Felty-Duckworth AM; Pekarek RS
J Med Chem; 1988 Aug; 31(8):1631-41. PubMed ID: 3398001
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the antimycoplasma activity of two commercially available tylosin premixes.
Ose EE; Tonkinson LV
Poult Sci; 1985 Feb; 64(2):287-93. PubMed ID: 3991415
[TBL] [Abstract][Full Text] [Related]
11. Efficacy trials in turkey poults with tylosin tartrate against Mycoplasma gallisepticum and Mycoplasma meleagridis.
Wise DR; Fuller MK
Res Vet Sci; 1975 Nov; 19(3):338-9. PubMed ID: 1215688
[TBL] [Abstract][Full Text] [Related]
12. Synergistic action of tylosin and oxytetracycline against bovine pasteurella isolates.
Ose EE
Vet Med Small Anim Clin; 1976 Jan; 71(1):92-5. PubMed ID: 1044184
[No Abstract] [Full Text] [Related]
13. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease.
Shryock TR; White DW; Staples JM; Werner CS
J Vet Diagn Invest; 1996 Jul; 8(3):337-44. PubMed ID: 8844577
[TBL] [Abstract][Full Text] [Related]
14. Studies of tylosin derivatives effective against macrolide-resistant strains: synthesis and structure-activity relationships.
Tsuchiya M; Hamada M; Takeuchi T; Umezawa H; Yamamoto K; Tanaka H; Kiyoshima K; Mori S; Okamoto R
J Antibiot (Tokyo); 1982 Jun; 35(6):661-72. PubMed ID: 7118722
[TBL] [Abstract][Full Text] [Related]
15. 5-O-Mycaminosyltylonolide antibacterial derivatives: design, synthesis and bioactivity.
Sugawara A; Maruyama H; Shibusawa S; Matsui H; Hirose T; Tsutsui A; Froyman R; Ludwig C; Koebberling J; Hanaki H; Kleefeld G; Ōmura S; Sunazuka T
J Antibiot (Tokyo); 2017 Jul; 70(8):878-887. PubMed ID: 28559578
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antimicrobial evaluation and structure-activity relationships within 23-modified derivatives of 5-O-mycaminosyltylonolide.
Kirst HA; Toth JE; Wind JA; Debono M; Willard KE; Molloy RM; Paschal JW; Ott JL; Felty-Duckworth AM; Counter FT
J Antibiot (Tokyo); 1987 Jun; 40(6):823-42. PubMed ID: 3610835
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity studies among 16-membered macrolide antibiotics related to tylosin.
Kirst HA; Wild GM; Baltz RH; Hamill RL; Ott JL; Counter FT; Ose EE
J Antibiot (Tokyo); 1982 Dec; 35(12):1675-82. PubMed ID: 7166533
[TBL] [Abstract][Full Text] [Related]
18. [Peptide derivatives of tylosin-related macrolides].
Korshunova GA; Sumbatian NV; Fedorova NV; Kuznetsova IV; Shishkina AV; Bogdanov AA
Bioorg Khim; 2007; 33(2):235-44. PubMed ID: 17476984
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens.
Hannan PC; O'Hanlon PJ; Rogers NH
Res Vet Sci; 1989 Mar; 46(2):202-11. PubMed ID: 2704885
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of 3,4''-ester derivatives of 16-membered macrolide antibiotics related to tylosin.
Kirst HA; Debono M; Willard KE; Truedell BA; Toth JE; Turner JR; Berry DR; Briggs BB; Fukuda DS; Daupert VM
J Antibiot (Tokyo); 1986 Dec; 39(12):1724-35. PubMed ID: 3818446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
